255 related articles for article (PubMed ID: 15048610)
1. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study.
Juckel G; Mavrogiorgou P; Bredemeier S; Gallinat J; Frodl T; Schulz C; Möller HJ; Hegerl U
Pharmacopsychiatry; 2004 Mar; 37(2):46-51. PubMed ID: 15048610
[TBL] [Abstract][Full Text] [Related]
2. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
3. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
Dardennes R; Lafuma A; Watkins S
Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
[TBL] [Abstract][Full Text] [Related]
4. [Insights in the central serotonergic function in patients with affective disorders].
Kawohl W; Hegerl U; Müller-Oerlinghausen B; Juckel G
Neuropsychiatr; 2008; 22(1):23-7. PubMed ID: 18381053
[TBL] [Abstract][Full Text] [Related]
5. [Long-term lithium prophylaxis in the bipolar affective disorder].
Suwalska A; Chłopocka-Woźniak M; Rybakowski J
Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity.
Juckel G; Gallinat J; Riedel M; Sokullu S; Schulz C; Möller HJ; Müller N; Hegerl U
Schizophr Res; 2003 Nov; 64(2-3):115-24. PubMed ID: 14613676
[TBL] [Abstract][Full Text] [Related]
7. Relationship between prophylactic effect of lithium therapy and family history of affective disorders.
Engström C; Aström M; Nordqvist-Karlsson B; Adolfsson R; Nylander PO
Biol Psychiatry; 1997 Sep; 42(6):425-33. PubMed ID: 9285078
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of lithium in the prophylaxis of affective disorders].
Ezquiaga E; García-López A; Nieves P; Rodríguez-Salvanés F
Actas Esp Psiquiatr; 2000; 28(3):156-60. PubMed ID: 11000697
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic functioning as measured by the loudness dependence of auditory evoked potentials is related to a haplotype in the brain-derived neurotrophic factor (BDNF) gene.
Juckel G; Schumacher C; Giegling I; Assion HJ; Mavrogiorgou P; Pogarell O; Mulert C; Hegerl U; Norra C; Rujescu D
J Psychiatr Res; 2010 Jun; 44(8):541-6. PubMed ID: 20004415
[TBL] [Abstract][Full Text] [Related]
10. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
[TBL] [Abstract][Full Text] [Related]
11. [Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness].
Roick C; Ahrens B; Becker T
Psychiatr Prax; 2001 Jul; 28 Suppl 1():S32-40. PubMed ID: 11533905
[TBL] [Abstract][Full Text] [Related]
12. Auditory evoked potentials and response to lithium prophylaxis.
Hegerl U; Ulrich G; Müller-Oerlinghausen B
Pharmacopsychiatry; 1987 Sep; 20(5):213-6. PubMed ID: 3671491
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
Licht RW; Vestergaard P; Brodersen A
Bipolar Disord; 2008 Feb; 10(1):79-86. PubMed ID: 18199244
[TBL] [Abstract][Full Text] [Related]
14. Prediction of lithium response in affective disorders.
Ananth J; Pecknold JC
J Clin Psychiatry; 1978 Feb; 39(2):95-100. PubMed ID: 344305
[TBL] [Abstract][Full Text] [Related]
15. Loudness dependence of evoked dipole source activity during acute serotonin challenge in females.
Norra C; Becker S; Bröcheler A; Kawohl W; Kunert HJ; Buchner H
Hum Psychopharmacol; 2008 Jan; 23(1):31-42. PubMed ID: 17868194
[TBL] [Abstract][Full Text] [Related]
16. The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls.
Park YM; Lee SH; Kim S; Bae SM
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):313-6. PubMed ID: 20005279
[TBL] [Abstract][Full Text] [Related]
17. The Tridimensional Personality Questionnaire and the intensity dependence of auditory evoked dipole source activity.
Juckel G; Schmidt LG; Rommelspacher H; Hegerl U
Biol Psychiatry; 1995 Mar; 37(5):311-7. PubMed ID: 7748982
[TBL] [Abstract][Full Text] [Related]
18. Who responds to prophylactic lithium therapy?
Abou-Saleh MT
Br J Psychiatry Suppl; 1993 Sep; (21):20-6. PubMed ID: 8217063
[TBL] [Abstract][Full Text] [Related]
19. Intensity dependence of auditory evoked potentials and clinical response to prophylactic lithium medication: a replication study.
Hegerl U; Wulff H; Müller-Oerlinghausen B
Psychiatry Res; 1992 Dec; 44(3):181-90. PubMed ID: 1289916
[TBL] [Abstract][Full Text] [Related]
20. Prediction of treatment response in major depression: integration of concepts.
Mulert C; Juckel G; Brunnmeier M; Karch S; Leicht G; Mergl R; Möller HJ; Hegerl U; Pogarell O
J Affect Disord; 2007 Mar; 98(3):215-25. PubMed ID: 16996140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
